-

UPC’s Paris Local Division may have to choose or design test for infringement by equivalence in gutter patent case
Read more: UPC’s Paris Local Division may have to choose or design test for infringement by equivalence in gutter patent caseThe UPC’s Paris LD now has to decide a gutter patent case, whereas the word “gutter” is meant literally and not meant to disparage the patent or the case.
-
UPC enabled Ecovacs’s inspection of Roborock household robots at last week’s IFA Berlin trade show; infringement suit pending
Read more: UPC enabled Ecovacs’s inspection of Roborock household robots at last week’s IFA Berlin trade show; infringement suit pendingThe Dusseldorf LD authorized evidence-gathering, but declined an invitation to allow an unfettered fishing excpedition. It may be the lengthiest operative part of a UPC order to date.
-
Samsung, Headwater settle wireless patent dispute
Read more: Samsung, Headwater settle wireless patent disputeSamsung and Headwater Research have settled a two-year patent infringement dispute.
-
UPC Roundup (1 week): PI granted despite debatable urgency, direct infringement clarified, protection of attorney–client privilege, new cases
Read more: UPC Roundup (1 week): PI granted despite debatable urgency, direct infringement clarified, protection of attorney–client privilege, new casesThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our September 6, 2025 UPC Roundup.
-
UPC’s Mannheim LD orders injunction, identifies direct infringement where two units of same product are combined to infringe
Read more: UPC’s Mannheim LD orders injunction, identifies direct infringement where two units of same product are combined to infringeIf a given product does not literally implement the patent invention alone, but two units of it are (and are intended to be) combined, then that’s direct infringement.
-
Regeneron makes strides in global Eylea patent enforcement campaign: settles with Sandoz, files fresh UK suits
Read more: Regeneron makes strides in global Eylea patent enforcement campaign: settles with Sandoz, files fresh UK suitsRegeneron has settled its year-long patent infringement dispute with Sandoz over several patents related to its eye disease drug Eylea, and filed a fresh lawsuit against two more rivals over the same drug in the High Court of Justice for England & Wales.
-
Pharma and Biotech Patent Litigation Summit Europe returns in 2026: rebranded event features tech industry track, UPC litigation forum
Read more: Pharma and Biotech Patent Litigation Summit Europe returns in 2026: rebranded event features tech industry track, UPC litigation forumKisaco Research’s annual Pharma and Biotech Patent Litigation Summit Europe will take place from January 19 to January 21 in the Beurs van Berlage, Amsterdam, with ip fray as an official media partner.


